Literature DB >> 29073658

Health data research in New Zealand: updating the ethical governance framework.

Angela Ballantyne1, Rochelle Style2.   

Abstract

Demand for health data for secondary research is increasing, both in New Zealand and worldwide. The New Zealand government has established a large research database, the Integrated Data Infrastructure (IDI), which facilitates research, and an independent ministerial advisory group, the Data Futures Partnership (DFP), to engage with citizens, the private sector and non-government organisations (NGOs) to facilitate trusted data use and strengthen the data ecosystem in New Zealand. We commend these steps but argue that key strategies for effective health-data governance remain absent in New Zealand. In particular, we argue in favour of the establishment of: (1) a specialist Health and Disability Ethics Committee (HDEC) to review applications for secondary-use data research; (2) a public registry of approved secondary-use research projects (similar to a clinical trials registry); and (3) detailed guidelines for the review and approval of secondary-use data research. We present an ethical framework based on the values of public interest, trust and transparency to justify these innovations.

Mesh:

Year:  2017        PMID: 29073658

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  3 in total

1.  Australian general practitioner perceptions to sharing clinical data for secondary use: a mixed method approach.

Authors:  Richard J Varhol; Sean Randall; James H Boyd; Suzanne Robinson
Journal:  BMC Prim Care       Date:  2022-07-01

2.  Social determinants and inequitable maternal and perinatal outcomes in Aotearoa New Zealand.

Authors:  Pauline Dawson; Benoit Auvray; Crystal Jaye; Robin Gauld; Jean Hay-Smith
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

3.  THEIA™ development, and testing of artificial intelligence-based primary triage of diabetic retinopathy screening images in New Zealand.

Authors:  E Vaghefi; S Yang; L Xie; S Hill; O Schmiedel; R Murphy; D Squirrell
Journal:  Diabet Med       Date:  2020-09-27       Impact factor: 4.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.